News: Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

5,966.00GBp
12 Feb 2016
Change (% chg)

119.00p (+2.04%)
Prev Close
5,847.00p
Open
5,876.00p
Day's High
5,972.00p
Day's Low
5,840.00p
Volume
1,537,216
Avg. Vol
1,109,226
52-wk High
6,450.00p
52-wk Low
5,403.00p

Search Stocks
Select another date:

Fri, Jan 29 2016

Brazil's Hypermarcas sells contraception unit to RB for 675 mln reais

RIO DE JANEIRO, Jan 29 Hypermarcas SA , the largest Brazilian producer of personal care goods, said on Friday its board has agreed to the sale of its contraception division to Britain's Reckitt Benckiser for 675 million reais ($169 million).

BRIEF-Reckitt Benckiser says to start 2016 share repurchase programme

* Will commence a 2016 share repurchase programme for up to a maximum consideration of 800 mln stg

British watchdog investigates Reckitt's Nurofen Express ad

Britain's advertising watchdog is investigating whether a television ad for Reckitt Benckiser Group's Nurofen Express pain relief tablets misled consumers with unfounded claims.

RPT-British watchdog investigates Reckitt's Nurofen Express ad

Dec 15 Britain's advertising watchdog is investigating whether a television ad for Reckitt Benckiser Group's Nurofen Express pain relief tablets misled consumers with unfounded claims.

Reckitt Benckiser misled consumers on Nurofen painkillers: Australian court

SYDNEY An Australian court ordered Reckitt Benckiser to pull several of its Nurofen pain relief products from the market, saying on Monday the British firm had misled consumers by marketing identical products for different types of pain.

UPDATE 2-Reckitt Benckiser misled consumers on Nurofen painkillers - Australian court

SYDNEY, Dec 14 An Australian court ordered Reckitt Benckiser to pull several of its Nurofen pain relief products from the market, saying on Monday the British firm had misled consumers by marketing identical products for different types of pain.

BRIEF-Reckitt Benckiser CFO comments on margin outlook

* CFO on conference call says no change to margin outlook for full year, but acknowledges that higher sales benefit profits.Further company coverage: (Reporting by Martinne Geller; editing by Jason Neely)

Reckitt Benckiser lifts outlook after sales top estimates

LONDON, Oct 21 Reckitt Benckiser Group raised its full-year sales outlook on Wednesday after reporting a bigger-than-expected gain in third-quarter sales helped by consumer health products.

BRIEF-Reckitt Benckiser raises FY LFL revenue target to 5 pct

* +7% LFL growth in Q3. Strategy for growth and outperformance, underpinned by innovation, is working in challenging and volatile markets.

BUZZ-Reckitt Benckiser: Brokerage Exane gets behind stock

** Consumer goods maker Reckitt Benckiser up c.2 pct & among top FTSE bluechip gainers with more than a 10th of daily avg volume traded through in first 30 mins, after Exane BNP Paribas grows bullish on the stock

Select another date:
Search Stocks